首页> 美国卫生研究院文献>Infectious Disease Reports >A case of invasive pulmonary aspergillosis during treatment for acute exacerbation of interstitial lung disease
【2h】

A case of invasive pulmonary aspergillosis during treatment for acute exacerbation of interstitial lung disease

机译:一例间质性肺疾病急性加重期间侵袭性肺曲霉病一例

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Prolonged immunosuppressive therapy is a risk factor for invasive pulmonary aspergillosis. We report a case of a 79-yearold man who underwent immunosuppressive therapy with methylprednisolone and cyclosporine for an acute exacerbation of interstitial lung disease. Ten days after initiation of immunosuppressive therapy, the patient reported night sweats and purulent sputum, and chest computed tomography scan revealed consolidation. He was diagnosed with invasive pulmonary aspergillosis, and required vasopressor support with oxygen therapy. After the administration of voriconazole and the modulation of immunosuppressive therapy, his condition improved. Short-term immunosuppressive therapy can also induce invasive pulmonary aspergillosis.
机译:长时间的免疫抑制治疗是侵袭性肺曲霉病的危险因素。我们报告了一例79岁的男子,他接受了甲基泼尼松龙和环孢霉素的免疫抑制治疗,急性加重了间质性肺疾病。免疫抑制治疗开始后十天,患者报告盗汗和脓性痰,胸部计算机断层扫描显示结实。他被诊断患有侵袭性肺曲霉病,需要通过氧气疗法支持升压药。伏立康唑给药和免疫抑制治疗后,病情得到改善。短期免疫抑制疗法还可以诱发侵袭性肺曲霉病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号